info@synchemia.com | sales@synchemia.com 
9766925136 | 72 
Alfuzosin
Alfuzosin | CAS NO: 81403-80-7, Alfuzosin is used to treat the signs and symptoms of benign enlargement of the prostate (benign prostatic hyperplasia or BPH).
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Alfuzosin impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities. Alfuzosin is used to treat the signs and symptoms of benign enlargement of the prostate (benign prostatic hyperplasia or BPH). Buy Reliable and High-Purity Alfuzosin Impurities, Delivered by Synchemia Research Chemicals.
Download catalogue
Pharmaceutical Reference Standards
Alfuzosin
| CAT No | SRC-A27041 |
| CAS No | 81403-80-7 |
| Mol.F. | C19H27N5O4 |
| Mol.Wt. | 389.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Alfuzosin Hydrochloride
| CAT No | SRC-A27042 |
| CAS No | 81403-80-7 |
| Mol.F. | C19H27N5O4 : HCl |
| Mol.Wt. | 389.5 : 36.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Alfuzosin EP Impurity A Hydrochloride
| CAT No | SRC-A27043 |
| CAS No | 98902-36-4 |
| Mol.F. | C19H23N5O4 : HCl |
| Mol.Wt. | 385.4 : 36.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Alfuzosin EP Impurity C Hydrochloride
| CAT No | SRC-A27044 |
| CAS No | 98902-34-2 |
| Mol.F. | C19H27N5O4 : HCl |
| Mol.Wt. | 389.5 : 36.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Alfuzosin EP Impurity D Hydrochloride
| CAT No | SRC-A27045 |
| CAS No | 76362-29-3 |
| Mol.F. | C14H21N5O2 : HCl |
| Mol.Wt. | 291.4 : 36.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Alfuzosin EP Impurity E Hydrochloride
| CAT No | SRC-A27046 |
| CAS No | 1026411-59-5 |
| Mol.F. | C15H21N5O3 : HCl |
| Mol.Wt. | 319.4 : 36.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Alfuzosin EP Impurity F Hydrochloride
| CAT No | SRC-A27047 |
| CAS No | 19216-53-6 |
| Mol.F. | C12H16N4O2 : HCl |
| Mol.Wt. | 248.3 : 36.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Alfuzosin EP Impurity D (Dihydrochloride Salt)
| CAT No | SRC-A27048 |
| CAS No | 76362-29-3 |
| Mol.F. | C14H21N5O2 : 2(HCl) |
| Mol.Wt. | 291.4 : 2(36.5)g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Alfuzosin EP Impurity B
| CAT No | SRC-A27049 |
| CAS No | 23680-84-4 |
| Mol.F. | C10H10CIN3O2 |
| Mol.Wt. | 239.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Alfuzosin EP Impurity C
| CAT No | SRC-A27050 |
| CAS No | 98902-34-2 |
| Mol.F. | C19H27N5O4 |
| Mol.Wt. | 389.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Alfuzosin EP Impurity D
| CAT No | SRC-A27051 |
| CAS No | 76362-29-3 |
| Mol.F. | C14H21N5O2 |
| Mol.Wt. | 291.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Alfuzosin EP Impurity G
| CAT No | SRC-A27052 |
| CAS No | 928780-95-4 |
| Mol.F. | C24H30N8O4 |
| Mol.Wt. | 494.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.
